Publications and Presentations on Aciont's Research

Recent Publications

An ongoing series of informational entries

December 6, 2018

Ophthalmology researchers discuss the first in human phase 1/2 clinical study and data of DSP-Visulex.

April 15, 2020

Ophthalmology researchers led by Molokhia et. al discuss various animal models (PK and efficacy) demonstrating the delivery of macromolecules using process known as electroosmosis. 

Other Recent Publications

An ongoing series of informational entries


David Miller and Kevin Li and colleagues discuss the effects of intraocular clearance using a topical ocular drug delivery system. 

November, 2017

Papangkorn and colleagues discuss efficacy in a pan uveitis (ocular inflammation induction) model in rabbit with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

February, 2018

Papangkorn and colleagues discuss drug transport kinetics and safety with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

Archived Research Presentations

An ongoing series of informational entries

By John Higuchi; Kongnara Papangkorn; Sarah Molokhia; Donald Mix; Charlotte Butler; Prasoona Karra; Balbir Brar; S. Kevin Li; William I. Higuchi

David Miller and Kevin Li and colleagues discuss the effects of intraocular clearance using a topical ocular drug delivery system. 

By Sarah A. Molokhia; Kongnara Papangkorn; Donald Mix; Charlotte Butler; Prasoona Karra; John Higuchi; Balbir Brar; S. Kevin Li; William I. Higuchi


By Sarah Molokhia; Kongnara Papangkorn; Charlotte Butler; Michael Burr; John Higuchi; Balbir Brar; Balamurali Ambati; William Higuchi


Research Presentations

An ongoing series of informational entries

By J. W. Higuchi; W. I. Higuchi; K. Papangkorn; S. K. Li; R. P. Kochambilli; A. L. Tuitupou; D. C. Mix, Jr.

Papangkorn and colleagues discuss efficacy in a pan uveitis (ocular inflammation induction) model in rabbit with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

By K. Papangkorn; D. C. Mix, Jr.; K. M. Gupta; J. W. Higuchi; B. Brar; S. K. Li; W. I. Higuchi

Papangkorn and colleagues discuss drug transport kinetics and safety with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

0